Induction of inflammatory mediator release (12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa.
The role of platelets in acute and chronic infection has been widely discussed in various disease processes. We studied the effects of two lipolytic enzymes (phospholipase C, lipase) secreted by Pseudomonas aeruginosa strains isolated from cystic fibrosis (CF) patients with regard to 12-hydroxyeicosatetraenoic acid (12-HETE) generation from human platelets. Both phospholipase C (PLC) and lipase were secreted into the culture supernatant at the end of the logarithmic growth phase. Indeed, only culture supernatants obtained from the late logarithmic/early stationary phase of CF strains induced the generation of 12-hydroxyeicosatetraenoic acid (12-HETE) (from 15 +/- 9 to 370 +/- 98 ng, n = 7). Purified P. aeruginosa lipase itself generated only small amounts of 12-HETE from human platelets with a maximum of 30 +/- 7 ng/10(8) platelets at the highest concentration tested (20 nkat). A partially purified culture supernatant from P. aeruginosa strain PAO1 containing phospholipase C and lipase, but lacking glycolipid and protease activities, induced time- and dose-dependently a significant 12-HETE generation from human platelets. Maximal 12-HETE generation was observed at the highest enzyme concentrations tested (PLC: 1.35 nkat, lipase: 3.7 nkat/10(8) platelets). To analyze whether lipase exhibits a modulatory role on PLC-induced 12-HETE generation from human platelets we inhibited lipase activity in the P. aeruginosa partially purified culture supernatant by treatment with the lipase-specific inhibitor hexadecylsulfonylfluoride (AMSF) leaving the activity of PLC unaffected (lipase-free culture supernatant). The capacity of lipase-free culture supernatant to induce 12-HETE generation was diminished by up to 100% depending on the PLC activity.(ABSTRACT TRUNCATED AT 250 WORDS)
König
B
B
AG Infektabwehr, Ruhr-Universität Bochum, BRD, FRG.
Jaeger
K E
KE
König
W
W
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D001792:Blood Platelets / Q000378:metabolism* / Q000382:microbiology; D003016:Clostridium perfringens / Q000201:enzymology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000097:blood*; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000097:blood*; D008049:Lipase / Q000502:physiology*; D011550:Pseudomonas aeruginosa / Q000201:enzymology*; D010738:Type C Phospholipases / Q000502:physiology*
D006893:Hydroxyeicosatetraenoic Acids; D018836:Inflammation Mediators; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D008049:Lipase; D010738:Type C Phospholipases